Qilian Mixture as an Adjunct Treatment During Gefitinib Therapy in Lung Adenocarcinoma Patients: A Randomized Controlled Clinical Trial With Mechanism Exploration
{{output}}
Aim: Targeted therapy is recommended for lung adenocarcinoma patients with epidermal growth factor receptor (EGFR) mutations. We aimed to investigate clinical efficacy and safety, as well as the potential underlying mechanisms, o... ...
